Literature DB >> 1332153

Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro.

A P Foster1, P Lees, F M Cunningham.   

Abstract

Platelet activating factor (PAF) is known to be a chemoattractant for equine neutrophils in vivo and in vitro. In this study the in vitro migratory response of equine eosinophils and neutrophils to PAF has been examined and compared with that to leukotriene (LT)B4. PAF (10(-8) to 10(-5) M), but not lyso-PAF (10(-6) M), caused dose related migration of both equine eosinophils and neutrophils, maximal responses occurring at 10(-6) M. Responses to PAF were inhibited by the receptor antagonist WEB 2086. LTB4 (10(-8) to 10(-6) M) also induced migration of both cell types, although the maximum effect was observed with a 10-fold lower concentration. Moreover, the maximum response of equine eosinophils to LTB4 was significantly greater than to PAF. It is concluded that LTB4 and PAF, if released in vivo at sites of allergic or inflammatory reactions, could mediate the recruitment of leucocytes to the involved tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332153     DOI: 10.1016/0034-5288(92)90114-h

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  In vitro and in vivo impact of a new glycosphingolipid on neutrophils.

Authors:  E Tubaro; C Croce; G Cavallo; L Belogi; G Guida; C Santiangeli; M G Cifone; A Santoni; F Mainiero
Journal:  Agents Actions       Date:  1994-10

2.  Actions of PAF receptor antagonists in horses with the allergic skin disease sweet itch.

Authors:  A P Foster; P Lees; F M Cunningham
Journal:  Inflamm Res       Date:  1995-10       Impact factor: 4.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.